1150103-09-5Relevant articles and documents
CCR5 ANTAGONISTS AS THERAPEUTIC AGENTS
-
Page/Page column 20; 22, (2009/06/27)
The present invention relates to compounds useful in the treatment of CCR5-related diseases and disorders, for example, useful in the inhibition of HIV replication, the prevention or treatment of an HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).
CCR5 ANTAGONISTS AS THERAPEUTIC AGENTS
-
Page/Page column 18-19, (2009/06/27)
The present invention relates to compounds useful in the treatment of CCR5-related diseases and disorders, for example, useful in the inhibition of HIV replication, the prevention or treatment of an HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).